« Back
Home /
Thiabendazole

Thiabendazole

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 g
Item no.	HY-B0263-5g
Targets	Mitochondrial Metabolism; Parasite
CASRN	148-79-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Thiabendazole is an orally available benzimidazole fungicide with repellent and anticancer activities. Thiabendazole can result in developmental malformations. Thiabendazole can be used for modeling[1][2][3][4][5].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	201.25
Clinical_Information	Launched
Manufacturers Research_Area	Cancer; Infection; Inflammation/Immunology; Cardiovascular Disease
Solubility	DMSO : 50 mg/mL (ultrasonic)\|H2O : < 0.1 mg/mL (ultrasonic)
Manufacturers Target	Caspase; CDK; Interleukin Related; MDM-2/p53; Mitochondrial Metabolism; Others; Parasite; VEGFR
Isoform	Caspase 3; Caspase 9; CDK1; CDK2; IL-1; IL-10; IL-13; IL-6
Pathway	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Others; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0263-5g-safety-datasheet.pdf